Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGF-Apan (Peptide) (N-Term) Antikörper

Der Kaninchen Polyklonal anti-VEGF-Apan (Peptide) Antikörper (ABIN1589724) detektiert spezifisch VEGF-Apan (Peptide) in IP und WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN1589724
-15% Promotion 2026
241,93 €
284,62 €
Sparen Sie 42,69 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 2 Werktagen

Kurzübersicht für VEGF-Apan (Peptide) (N-Term) Antikörper (ABIN1589724)

Target

VEGF-Apan (Peptide)

Reaktivität

Human

Wirt

Kaninchen

Klonalität

Polyklonal

Applikation

Immunoprecipitation (IP), Western Blotting (WB)
  • Bindungsspezifität

    N-Term

    Verwendungszweck

    VEGF-Apan (Peptide) antibody

    Spezifität

    N-terminal peptide (20aa) of native human VEGF165

    Produktmerkmale

    Chromosomal location: 6p12
    Produced from sera of rabbits immunized with a highly purified N-terminal peptide of human VEGF-A.

    Aufreinigung

    Anti-VEGF-A was purified by affinity chromatography with immobilized Protein A.

    Immunogen

    N-terminal peptide (20aa) of native human VEGF165

    Isotyp

    IgG
  • Applikationshinweise

    IP: Use 1-5 μg/mL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS

    Handhabung

    Centrifuge vial prior to opening.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

    Haltbarkeit

    24 months
  • Target

    VEGF-Apan (Peptide)

    Hintergrund

    VEGFA, VPF, VEGF, MVCD1,Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF) or vasculotropin, is a homodimeric 34 - 42 kDa, heparin-binding glycoprotein with potent angiogenic, mitogenic and vascular permeability-enhancing activities specific for endothelial cells. Different isoforms can be generated by differential splicing (e.g. VEGF165). All eight cysteine residues involved in intra- and inter-chain disulfide bonds are conserved among these growth factors. A cDNA encoding a protein having a 53 % amino acid sequence homology in the PDGF-like region of VEGF has been isolated from a human placental cDNA library. This protein, named placenta growth factor (PlGF), is now recognized to be a member of the VEGF family of growth factors. Two receptor tyrosine kinases have been described as putative VEGF receptors. Flt-1 (fms-like tyrosine kinase), and KDR (kinase-insert-domain-containing receptor) proteins have been shown to bind VEGF-A with high affinity. In vitro, VEGF is a potent endothelial cell mitogen. The antibody is against the N-terminus and will recognize all VEGF-A isoforms.

    Gen-ID

    7422

    NCBI Accession

    NM_001171626, NP_001165097

    UniProt

    P15692
Sie sind hier:
Chat with us!